Canaan Partners | Investor Profile

Portfolio companies

Canaan Partners is on record against 58 companies.

Abyrx Aceiss Acesion Pharma ApS Actio Biosciences, Inc. ACTIVE Network ActualyzeAI, Inc. Advanced BioHealing Aer Therapeutics, Inc. Aeva Agomab Therapeutics Aim Security AirEye Alkymi Alphina Therapeutics Alsius Corporation AlterEgo Networks Alterome Therapeutics, Inc. Altimate Inc. Ambra Health Amicus Therapeutics Antiva Biosciences Apartment List Apex.AI Apieron apisec.ai Appsmith Arbor Arbor Networks Arcade Archipelago Argon Networks Arrakis Therapeutics Artie Arvinas Associated Content Astra AtheroMed Attotude Inc. Autobahn Therapeutics, Inc. Axcelius I/II Axis Security Azibo Basebuild, Inc. Beckon Bellhop Berkshire Grey Bev Binarly BiPar Sciences, Inc. Bird Blurb Bond Bravo Sierra Brigit Bumblebee Spaces Bumped Buzzer Bzaar

Investment focus

We invest at seed and Series A stages in de novo tech and healthcare companies, with a deliberate 60/40 sector split. Our focus is on the U.S. market, leveraging a transparent, debate-driven partner scoring system and multi-generation continuity.

Related investors

CanaanAlso backs Arrakis Therapeutics and Bird and 56 more of the same companies
Airbus VenturesAlso backs Apex.AI and Astra
Nyca PartnersAlso backs Brigit and Astra
Correlation VenturesAlso backs Astra
RET VenturesAlso backs Azibo

All investors with a sourced record →

Get a deep full report on Canaan Partners → Get warm-intro paths to Canaan Partners → See how VCs use MentionFox →